The Biologic Used in Dermatology That’s Proving Effective for Joint Disease

Dupilumab, the biologic originally developed and approved for moderate-to-severe atopic dermatitis, is now showing remarkable promise in treating...

Dupilumab, the biologic originally developed and approved for moderate-to-severe atopic dermatitis, is now showing remarkable promise in treating...

Patients are reporting suicidal thoughts while taking GLP-1 receptor agonist drugs like Ozempic, Wegovy, and Zepbound, but the FDA's largest review to...

A new class of obesity drug does something no previous weight-loss medication has managed: it fundamentally rewires the brain's reward circuitry rather...

For decades, chemotherapy paired with radiation has been the backbone of cervical cancer treatment, even for patients with early-stage disease who might...

Despite the hopeful framing of this headline, the full picture requires an honest clarification: as of March 2026, no oral drug has yet received FDA...

A new wave of psoriasis treatments is pushing the boundaries of what dermatologists once thought possible, with several drugs now achieving total skin...

A class of oral drugs designed to dissolve blood clots — sometimes referred to as oral thrombectomy agents or next-generation thrombolytics — has been...

A single intravenous infusion is now capable of freeing people with Hemophilia B from a lifetime of routine clotting factor injections.

Levodopa, often sold under the brand name Sinemet when combined with carbidopa, remains the gold standard drug for controlling Parkinson's tremors while...

A topical minocycline foam called Zilxi is rapidly changing how dermatologists treat rosacea, offering the anti-inflammatory benefits of oral antibiotics...